选择性雌激素受体调节剂
三苯氧胺
雌激素受体
雌激素
荧光素酶
转染
下调和上调
雌激素受体
报告基因
雌激素受体α
化学
抗雌激素
雌激素相关受体γ
受体
雌激素相关受体α
内分泌学
内科学
癌症研究
药理学
医学
基因表达
癌症
乳腺癌
基因
生物化学
出处
期刊:Herald of Medicine
日期:2004-01-01
摘要
Objective:To investigate the induction of estr ogen receptor(ER)-α and -β activities by selective estrogen receptor modifie rs (SERMs). Methods:Breast cancer cell lines MDA-MB 231 were transf ected with the vector expressing ERα, β(pSVhER α/β) in combination with a lu ciferase reporter gene vector(ER-Etk-Luc). The transfected cells were separate ly treated with estrogen and several SERMs at a dose of 1 nmol·L -1 for 2 4 hours. To assess the luciferase expression in cells transfected with ERα or β, the commercially available luciferase reporter gene assay was used. Results:ERα activities were strikingly up-regulated in the presence of raloxifen, 4OH-tamoxifen and tamoxifen citrate as 17β estradi ol, while ERβ activities were much more weakly induced in the presence of ralox ifen, 4OH-tamoxifen and tamoxifen citrate. Conclusion:Our results indicate that the antiestrogenic activity of SERMs is brought about chiefly via upregulation of estrogen receptor -α while the estrogen β receptor was induced only to a much lessor extent.
科研通智能强力驱动
Strongly Powered by AbleSci AI